文献速递产科母胎医学

血压控制水平对轻中度妊娠期高血压孕妇围产结局的影响

[Effect of blood pressure control level on perinatal outcomes in women with mild-moderate gestational hypertension].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2017-01-01

回顾性分析北京大学第三医院2012年1月至2016年12月344例初始诊断为轻中度妊娠期高血压的孕妇,按孕期血压控制和维持水平分为四组,比较重度妊娠期高血压、伴蛋白尿的子痫前期、重度子痫前期及小于胎龄儿的发生率。结果示良好的血压控制有利于降低重度妊娠期高血压和重度子痫前期的发生率,但对小于胎龄儿的发生无明显影响。

要点

  • A组重度妊娠期高血压发生率低于B组,B组重度妊娠期高血压和重度子痫前期发生率低于C组(P<0.05)。
  • 四组伴蛋白尿的子痫前期和小于胎龄儿发生率分别比较,差异均无统计学意义(P>0.05)。
  • 药物降压孕妇起始血压水平和孕期血压维持水平是重度妊娠期高血压的独立危险因素。

核心结论

  • 轻中度妊娠期高血压孕妇孕期血压进行良好的控制和维持,有利于降低重度妊娠期高血压和重度子痫前期的发生率,但对小于胎龄儿的发生并无明显影响。

研究设计与样本

  • 回顾性分析2012年1月至2016年12月于北京大学第三医院产前检查并终止妊娠、资料完整的344例初始诊断为轻中度妊娠期高血压的孕妇。
  • 根据孕期血压控制和维持水平(以收缩压和舒张压中较高1项分组)分为四组:A组<130/80 mmHg 135例,B组(130~139)/(80~89)mmHg 160例,C组(140~149)/(90~99)mmHg 46例,D组(150~159)/(100~109)mmHg 3例。

主要发现

  • A组孕妇重度妊娠期高血压的发生率明显低于B组(P<0.05),B组孕妇重度妊娠期高血压和重度子痫前期的发生率明显低于C组(P<0.05)。
  • D组孕妇重度妊娠期高血压的发生率与A组、B组和C组分别比较,差异均无统计学意义(P>0.05)。
  • 四组孕妇伴蛋白尿的子痫前期、小于胎龄儿的发生率分别比较,差异均无统计学意义(P>0.05)。
  • 48例使用药物降压的孕妇中,起始血压为(140~149)/(90~99)mmHg孕妇的重度妊娠期高血压发生率明显低于起始血压≥160/110 mmHg者(P<0.05)。
  • 药物降压孕妇起始血压水平(OR=3.566,95%CI为1.080~11.771,P=0.037)和孕期血压控制和维持水平(OR=4.787,95%CI为1.115~20.551,P=0.035)是重度妊娠期高血压的独立危险因素。

关键数值与推荐

  • 孕妇水肿(OR=2.651,95%CI为1.628~4.316,P=0.000)、胎儿生长受限(OR=1.103,95%CI为1.427~5.914,P=0.002)、轻中度妊娠期高血压的发病孕周(OR=0.755,95%CI为0.578~0.985,P=0.038)是伴蛋白尿的子痫前期发生的独立危险因素。
  • 有胎儿生长受限趋势(OR=17.787,95%CI为1.833~40.396,P=0.000)、既往有子痫前期史(OR=5.294,95%CI为1.086~25.800,P=0.039)、孕期血压水平(OR=2.109,95%CI为1.274~3.491,P=0.004)是重度子痫前期发生的独立危险因素。
  • 有胎儿生长受限趋势(OR=25.622,95%CI为2.596~252.864,P=0.005)孕妇的胎儿小于胎龄儿的发生率更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of blood pressure (BP) control level on perinatal outcomes in women with mild-moderate gestational hypertension (GHp). Methods: Totally, 344 women diagnosed initially as mild-moderate GHp who delivered in Peking University Third Hospital from January 2012 to December 2016 were recruited. They were divided into four groups according to the stabilized level of BP during pregnancy. (1) Group A: BP<130/80 mmHg (1 mmHg=0.133 kPa) ; (2) Group B: BP (130-139) / (80-89) mmHg; (3) Group C: BP (140-149) / (90-99) mmHg; (4) Group D: BP (150-159) / (100-109) mmHg. The clinical profile and incidence of severe GHp, pre-eclampsia with proteinuria (PE+Upro), severe pre-eclampsia (sPE), small-for-gestational age (SGA) were compared among the four groups. Student t-test was preformed to normal distributive data and Kruskal-Wallis test was used to non-normally distributed variables. Chi-square test was used in count data. Logistic regression analysis was adopted for multiple-factor analysis. Results: (1) The incidence of severe GHp in group A was lower than group B (P<0.05). The incidences of severe GHp and sPE in the group B was lower than those in group C (P<0.05). While there was no difference in the incidence of PE+Upro and SGA among the four groups (P>0.05). And the incidence of severe GHp in group D had no difference with group A, B, C (P>0.05). (2) In the 48 patients who used medications to control BP, the occurence of severe GHp in those whose initial BP was (140-149) / (90-99) mmHg was lower than those of ≥160/110 mmHg (P<0.05). But the incidence of severe GHp had no significant difference between patients whose initial BP was (140-149) / (90-99) mmHg and patients whose initial BP was (150-159) / (100-109) mmHg (P>0.05). The initial BP level had no impact on the incidence of PE+Upro, sPE and SGA (P>0.05). (3) Multivariate logistic regression analysis showed that the BP level before using medications (OR=3.566, 95%CI: 1.080-11.771, P=0.037) and the BP level maintained (OR=4.787, 95%CI: 1.115-20.551, P=0.035) were independent factor that affected the incidence of severe GHp. Edema (OR=2.651, 95% CI: 1.628-4.316 P=0.000), fetal growth restriction (FGR; OR=1.103, 95% CI: 1.427-5.914, P=0.002) and the onset gestational age of GHp (OR=0.755, 95%CI: 0.578-0.985, P=0.038) were independent factors that affected the incidence of PE+Upro. The tendency of FGR (OR=17.787, 95%CI: 1.833-40.396 P=0.000), history of PE (OR=5.294, 95%CI: 1.086-25.800, P=0.039) and the BP level during pregnancy (OR=2.109, 95%CI: 1.274-3.491, P=0.004) were independent factors affecting the incidence of sPE. FGR tendency was independent factor affecting the incidence of SGA (OR=25.622, 95%CI: 2.596-252.864, P=0.005). Conclusion: A satisfied control of BP is helpful to reduce severe GHp and sPE, but the incidence of SGA does not affected. 目的: 分析轻中度妊娠期高血压(GHp)孕妇的孕期血压控制和维持水平对母儿结局的影响。 方法: 收集2012年1月至2016年12月于北京大学第三医院进行产前检查并终止妊娠、资料完整的344例初始诊断为轻中度GHp的孕妇,对其临床资料进行分析。根据其孕期血压控制和维持水平(以收缩压和舒张压中较高1项分组)分为4组,(1)A组:<130/80 mmHg(1 mmHg=0.133 kPa)135例;(2)B组:(130~139)/(80~89)mmHg 160例;(3)C组:(140~149)/(90~99)mmHg 46例;(4)D组:(150~159)/(100~109)mmHg 3例。比较4组产妇的临床特征及重度GHp、伴蛋白尿的子痫前期(PE+Upro)、重度子痫前期(sPE)以及小于胎龄儿(SGA)的发生率。正态分布的计量资料采用t检验,非正态分布的计量资料采用Kruskal-Wallis检验,计数资料采用χ(2)检验,多因素分析采用logistic回归分析。 结果: (1)4组孕妇重度GHp、PE+Upro、sPE、SGA的发生率:A组孕妇重度GHp的发生率明显低于B组(P<0.05),B组孕妇重度GHp和sPE的发生率明显低于C组(P<0.05),D组孕妇重度GHp的发生率与A组、B组和C组分别比较,差异均无统计学意义(P>0.05)。4组孕妇PE+Upro、SGA的发生率分别比较,差异均无统计学意义(P>0.05)。(2)使用药物降压的轻中度GHp孕妇的起始血压及母儿结局:48例使用药物降压的孕妇中,起始血压为(140~149)/(90~99)mmHg孕妇的重度GHp发生率明显低于起始血压≥160/110 mmHg者(P<0.05),但起始血压为(140~149)/(90~99)mmHg、(150~159)/(100~109)mmHg孕妇重度GHp的发生率比较,差异无统计学意义(P>0.05)。起始血压水平与使用药物降压孕妇的PE+Upro、sPE、SGA发生率无关(P>0.05)。(3)多因素logistic回归分析显示,药物降压孕妇的起始血压水平(OR=3.566,95%CI为1.080~11.771,P=0.037)和孕期血压控制和维持水平(OR=4.787,95%CI为1.115~20.551,P=0.035)是轻中度GHp孕妇发生重度GHp的独立危险因素;孕妇水肿(OR=2.651,95%CI为1.628~4.316,P=0.000)、胎儿生长受限(FGR;OR=1.103,95%CI为1.427~5.914,P=0.002)、轻中度GHp的发病孕周(OR=0.755,95%CI为0.578~0.985,P=0.038)是PE+Upro发生的独立危险因素;有FGR趋势(是指在产前检查中发现宫高小于同孕周平均值;OR=17.787,95%CI为1.833~40.396,P=0.000)、既往有PE史(OR=5.294,95%CI为1.086~25.800,P=0.039)、孕期血压水平(OR=2.109,95%CI为1.274~3.491,P=0.004)是sPE发生的独立危险因素。有FGR趋势(OR=25.622,95%CI为2.596~252.864,P=0.005)孕妇的胎儿SGA的发生率更高。 结论: 轻中度GHp孕妇孕期血压进行良好的控制和维持,有利于降低重度GHp和sPE的发生率,但对SGA的发生并无明显影响。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Shen Y, Yang Z, Chen Y, et al. [Effect of blood pressure control level on perinatal outcomes in women with mild-moderate gestational hypertension]. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 28954446. doi:10.3760/cma.j.issn.0529-567X.2017.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。